Population Pharmacokinetic Model Assessment of the Effects of Body Weight on Risk of Drug–Drug Interactions After Posaconazole Discontinuation

Documenti analoghi

• Predicting Pharmacokinetic Variability and Drug Interaction Risk Using Omics‐Based Biomarkers
  di: Bhagwat Prasad
  Pubblicazione: (2026)
• Effect of Valemetostat on the Pharmacokinetics of Midazolam and Digoxin: A Phase 1 Drug–Drug Interaction Study in Patients With Non‐Hodgkin Lymphoma
  di: Masaya Tachibana, et al.
  Pubblicazione: (2025)
• Assessment of Food Effect and pH‐Dependent Drug–Drug Interactions of Fruquintinib in Healthy Subjects
  di: Martha Gonzalez, et al.
  Pubblicazione: (2025)
• Utilization of Machine Learning Approaches for Drug Clearance Prediction and Population Pharmacokinetic Covariate Analysis
  di: Atul Rawal, et al.
  Pubblicazione: (2025)
• Tutorial Drug–Drug Interactions
  di: Edward M. Sellers
  Pubblicazione: (2025)